TRIA Bioscience specializes in the development of advanced hearing technologies aimed at enhancing the capabilities of biomedical equipment manufacturers. Their focus encompasses a range of products, including hearing assessment tools, hearing aids, and cochlear implants. By leveraging the latest advancements in science and engineering, TRIA Bioscience creates innovative diagnostic and assistive devices that significantly improve the evaluation and treatment of hearing-related conditions. Their commitment to research and innovation positions them as a leader in the hearing healthcare industry.

As a business-to-business (B2B) enterprise, TRIA Bioscience collaborates directly with major manufacturers of diagnostic and assistive devices. Their business model includes conducting scientific research to inform new technology development, improving existing products, and facilitating technology transfer through licensing agreements with interested manufacturers worldwide. This strategic approach not only enhances their product offerings but also contributes to the overall advancement of hearing technology in the healthcare sector.

United States

TRIA’s core competencies encompass the discovery and research of immune-based therapeutics. Developing vaccines for influenza, nicotine, and more.

TRIA Bioscience

Company Details